First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 168.42 USD 1.21%
Updated: Apr 22, 2024

Intrinsic Value

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. [ Read More ]

The intrinsic value of one ABBV stock under the Base Case scenario is 141.14 USD. Compared to the current market price of 168.42 USD, Abbvie Inc is Overvalued by 16%.

Key Points:
ABBV Intrinsic Value
Base Case
141.14 USD
Overvaluation 16%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Abbvie Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ABBV stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Abbvie Inc

Provide an overview of the primary business activities
of Abbvie Inc.

What unique competitive advantages
does Abbvie Inc hold over its rivals?

What risks and challenges
does Abbvie Inc face in the near future?

Has there been any significant insider trading activity
in Abbvie Inc recently?

Summarize the latest earnings call
of Abbvie Inc.

What significant events have occurred
in Abbvie Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Abbvie Inc.

Provide P/S
for Abbvie Inc.

Provide P/E
for Abbvie Inc.

Provide P/OCF
for Abbvie Inc.

Provide P/FCFE
for Abbvie Inc.

Provide P/B
for Abbvie Inc.

Provide EV/S
for Abbvie Inc.

Provide EV/GP
for Abbvie Inc.

Provide EV/EBITDA
for Abbvie Inc.

Provide EV/EBIT
for Abbvie Inc.

Provide EV/OCF
for Abbvie Inc.

Provide EV/FCFF
for Abbvie Inc.

Provide EV/IC
for Abbvie Inc.

Show me price targets
for Abbvie Inc made by professional analysts.

What are the Revenue projections
for Abbvie Inc?

How accurate were the past Revenue estimates
for Abbvie Inc?

What are the Net Income projections
for Abbvie Inc?

How accurate were the past Net Income estimates
for Abbvie Inc?

What are the EPS projections
for Abbvie Inc?

How accurate were the past EPS estimates
for Abbvie Inc?

What are the EBIT projections
for Abbvie Inc?

How accurate were the past EBIT estimates
for Abbvie Inc?

Compare the revenue forecasts
for Abbvie Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Abbvie Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Abbvie Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Abbvie Inc compared to its peers.

Compare the P/E ratios
of Abbvie Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Abbvie Inc with its peers.

Analyze the financial leverage
of Abbvie Inc compared to its main competitors.

Show all profitability ratios
for Abbvie Inc.

Provide ROE
for Abbvie Inc.

Provide ROA
for Abbvie Inc.

Provide ROIC
for Abbvie Inc.

Provide ROCE
for Abbvie Inc.

Provide Gross Margin
for Abbvie Inc.

Provide Operating Margin
for Abbvie Inc.

Provide Net Margin
for Abbvie Inc.

Provide FCF Margin
for Abbvie Inc.

Show all solvency ratios
for Abbvie Inc.

Provide D/E Ratio
for Abbvie Inc.

Provide D/A Ratio
for Abbvie Inc.

Provide Interest Coverage Ratio
for Abbvie Inc.

Provide Altman Z-Score Ratio
for Abbvie Inc.

Provide Quick Ratio
for Abbvie Inc.

Provide Current Ratio
for Abbvie Inc.

Provide Cash Ratio
for Abbvie Inc.

What is the historical Revenue growth
over the last 5 years for Abbvie Inc?

What is the historical Net Income growth
over the last 5 years for Abbvie Inc?

What is the current Free Cash Flow
of Abbvie Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Abbvie Inc.

Financials

Balance Sheet Decomposition
Abbvie Inc

Current Assets 33B
Cash & Short-Term Investments 12.8B
Receivables 11.2B
Other Current Assets 9B
Non-Current Assets 101.7B
Long-Term Investments 304m
PP&E 5B
Intangibles 87.9B
Other Non-Current Assets 8.5B
Current Liabilities 37.8B
Accounts Payable 30.7B
Other Current Liabilities 7.2B
Non-Current Liabilities 86.5B
Long-Term Debt 52.2B
Other Non-Current Liabilities 34.3B
Efficiency

Earnings Waterfall
Abbvie Inc

Revenue
54.3B USD
Cost of Revenue
-18.2B USD
Gross Profit
36.1B USD
Operating Expenses
-19.5B USD
Operating Income
16.6B USD
Other Expenses
-11.7B USD
Net Income
4.8B USD

Free Cash Flow Analysis
Abbvie Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

ABBV Profitability Score
Profitability Due Diligence

Abbvie Inc's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Free Cash Flow
Positive Gross Profit
Positive Operating Income
69/100
Profitability
Score

Abbvie Inc's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

ABBV Solvency Score
Solvency Due Diligence

Abbvie Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
Positive Net Debt
32/100
Solvency
Score

Abbvie Inc's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABBV Price Targets Summary
Abbvie Inc

Wall Street analysts forecast ABBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABBV is 188.18 USD with a low forecast of 162.61 USD and a high forecast of 217.35 USD.

Lowest
Price Target
162.61 USD
3% Downside
Average
Price Target
188.18 USD
12% Upside
Highest
Price Target
217.35 USD
29% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ABBV Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ABBV Price
Abbvie Inc

1M 1M
-6%
6M 6M
+16%
1Y 1Y
+3%
3Y 3Y
+66%
5Y 5Y
+160%
10Y 10Y
+388%
Annual Price Range
168.42
52w Low
132.51
52w High
182.1
Price Metrics
Average Annual Return 25.37%
Standard Deviation of Annual Returns 6.87%
Max Drawdown -22%
Shares Statistics
Market Capitalization 297.4B USD
Shares Outstanding 1 770 650 000
Percentage of Shares Shorted 0.74%

ABBV Return Decomposition
Main factors of price return

What is price return decomposition?

ABBV News

Other Videos

Last Important Events
Abbvie Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Abbvie Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Abbvie Inc Logo
Abbvie Inc

Country

United States of America

Industry

Biotechnology

Market Cap

297.4B USD

Dividend Yield

3.69%

Description

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Illinois and currently employs 50,000 full-time employees. The company went IPO on 2013-01-02. The firm is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products include Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The firm's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.

Contact

ILLINOIS
North Chicago
1 N Waukegan Rd
+18479327900.0
https://www.abbvie.com/

IPO

2013-01-02

Employees

50 000

Officers

Chairman & CEO
Mr. Richard A. Gonzalez
President & COO
Mr. Robert A. Michael
Executive VP & CFO
Mr. Scott T. Reents
Executive VP & COO
Dr. Azita Saleki-Gerhardt Ph.D.
Executive VP & Chief Commercial Officer
Mr. Jeffrey Ryan Stewart
Senior VP & Chief Scientific Officer of Global Research
Dr. Thomas J. Hudson M.D.
Show More
Senior Vice President of Investor Relations
Ms. Elizabeth Shea
Executive VP, General Counsel & Secretary
Mr. Perry C. Siatis
Senior VP, Chief Ethics, Compliance Officer & Allergan Aesthetic Legal
Mr. Sanjay Narayan
Executive VP & Chief Human Resources Officer
Mr. Timothy J. Richmond
Show Less

See Also

Discover More
What is the Intrinsic Value of one ABBV stock?

The intrinsic value of one ABBV stock under the Base Case scenario is 141.14 USD.

Is ABBV stock undervalued or overvalued?

Compared to the current market price of 168.42 USD, Abbvie Inc is Overvalued by 16%.